Anthony J. Gill focuses on Pathology, Internal medicine, Cancer research, Pancreatic cancer and Germline mutation. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Endocrinology and Oncology. The concepts of his Cancer research study are interwoven with issues in Carcinogenesis, Cancer, MLH1, Mutation and MSH2.
His Mutation study introduces a deeper knowledge of Genetics. Anthony J. Gill has researched Pancreatic cancer in several fields, including Clinical trial, Bioinformatics, Surgery, KRAS and CDKN2A. His research integrates issues of Point mutation and Germline in his study of Germline mutation.
His primary areas of study are Pathology, Internal medicine, Immunohistochemistry, Cancer research and Oncology. The Pathology study combines topics in areas such as Germline mutation and SDHB. His Internal medicine research incorporates elements of Gastroenterology and Endocrinology.
Anthony J. Gill interconnects Carcinogenesis, Cancer and Mutation in the investigation of issues within Cancer research. His biological study deals with issues like Colorectal cancer, which deal with fields such as Microsatellite instability. His studies in Pancreatic cancer integrate themes in fields like Neoadjuvant therapy and Surgery.
Anthony J. Gill spends much of his time researching Pathology, Internal medicine, Cancer research, Oncology and Immunohistochemistry. As part of one scientific family, Anthony J. Gill deals mainly with the area of Pathology, narrowing it down to issues related to the Targeted therapy, and often Mutation. He studied Internal medicine and Gastroenterology that intersect with Pancreas.
His research in Cancer research tackles topics such as Carcinogenesis which are related to areas like Dysplasia. Anthony J. Gill focuses mostly in the field of Immunohistochemistry, narrowing it down to topics relating to Disease and, in certain cases, Parathyroid gland and Surgical pathology. His Pancreatic cancer research includes elements of Neoadjuvant therapy and Surgery.
His main research concerns Pathology, Immunohistochemistry, Sarcoma, Internal medicine and Pancreatic cancer. His biological study spans a wide range of topics, including Targeted therapy and Multiple endocrine neoplasia type 2. His Immunohistochemistry study incorporates themes from Staining, Antibody, Succinate dehydrogenase and Cancer research.
His Cancer research study combines topics in areas such as Carcinogenesis, Locally advanced, Dysplasia and Intraepithelial neoplasia. Anthony J. Gill has included themes like Gastroenterology and Oncology in his Internal medicine study. His work deals with themes such as Neoadjuvant therapy, Biomarker, Exome, Pancreatic cysts and Gene dosage, which intersect with Pancreatic cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genomic analyses identify molecular subtypes of pancreatic cancer
Bailey P;Chang Dk;Nones K;Nones K;Johns Al.
Whole genomes redefine the mutational landscape of pancreatic cancer.
Nicola Waddell;Marina Pajic;Ann Marie Patch;David K. Chang.
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Andrew V. Biankin;Andrew V. Biankin;Andrew V. Biankin;Nicola Waddell;Karin S. Kassahn;Marie Claude Gingras.
Pan-cancer analysis of whole genomes
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Benjamin J. Raphael;Ralph H. Hruban;Andrew J. Aguirre;Richard A. Moffitt.
Cancer Cell (2017)
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.
Vinod P. Balachandran;Marta Łuksza;Julia N. Zhao;Vladimir Makarov.
Whole-genome landscape of pancreatic neuroendocrine tumours
Aldo Scarpa;David K. Chang;Katia Nones;Katia Nones;Vincenzo Corbo.
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
Zheng S;Cherniack Ad;Cherniack Ad;Dewal N;Moffitt Ra.
Cancer Cell (2016)
Margin Clearance and Outcome in Resected Pancreatic Cancer
David K. Chang;Amber L. Johns;Neil D. Merrett;Anthony J. Gill.
Journal of Clinical Oncology (2009)
miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer
Patsy Siok Hwa Soon;Lyndal J Tacon;Anthony J Gill;Christopher P Bambach.
Clinical Cancer Research (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: